Stock AZN ASTRAZENECA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Revisions AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
76.9 USD -0.18% Intraday chart for AstraZeneca PLC -0.36% +14.18%
May. 17 Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial RE
May. 16 AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. AZN Stock
  4. AZN Stock
  5. Revisions AstraZeneca PLC
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW